Page last updated: 2024-09-03

2-(4-morpholinyl)-4h-1-benzopyran-4-one and ku-0060648

2-(4-morpholinyl)-4h-1-benzopyran-4-one has been researched along with ku-0060648 in 1 studies

Compound Research Comparison

Studies
(2-(4-morpholinyl)-4h-1-benzopyran-4-one)
Trials
(2-(4-morpholinyl)-4h-1-benzopyran-4-one)
Recent Studies (post-2010)
(2-(4-morpholinyl)-4h-1-benzopyran-4-one)
Studies
(ku-0060648)
Trials
(ku-0060648)
Recent Studies (post-2010) (ku-0060648)
60018015

Protein Interaction Comparison

ProteinTaxonomy2-(4-morpholinyl)-4h-1-benzopyran-4-one (IC50)ku-0060648 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.0001
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)0.005
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)0.005
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.004
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.0005
Serine/threonine-protein kinase mTORHomo sapiens (human)10
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.59
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.005
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.005

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardos, J; Cano, C; Golding, BT; Griffin, RJ; Hardcastle, IR; Parveen, N; Payne, SL; Peacock, M; Rodriguez-Aristegui, S1

Other Studies

1 other study(ies) available for 2-(4-morpholinyl)-4h-1-benzopyran-4-one and ku-0060648

ArticleYear
Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.
    Bioorganic & medicinal chemistry letters, 2010, Jun-15, Volume: 20, Issue:12

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Chromones; Coumarins; DNA-Activated Protein Kinase; Humans; Inhibitory Concentration 50; Isocoumarins; Structure-Activity Relationship

2010